589 related articles for article (PubMed ID: 16217586)
1. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
4. [Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment].
Di Munno O; Delle Sedie A
Reumatismo; 2006; 58(1):11-21. PubMed ID: 16639483
[TBL] [Abstract][Full Text] [Related]
5. Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review.
Jayasena A; Atapattu N; Lekamwasam S
Int J Rheum Dis; 2015 Mar; 18(3):287-93. PubMed ID: 25923606
[TBL] [Abstract][Full Text] [Related]
6. [Glucocorticoid-induced osteoporosis].
Papierska L; Rabijewski M
Pol Arch Med Wewn; 2007 Aug; 117(8):363-9. PubMed ID: 18018384
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
8. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
Soybilgic A; Tesher M; Wagner-Weiner L; Onel KB
Pediatr Rheumatol Online J; 2014; 12():24. PubMed ID: 25053923
[TBL] [Abstract][Full Text] [Related]
9. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
[TBL] [Abstract][Full Text] [Related]
10. [Glucocorticoid induced osteoporosis].
Anić B; Mayer M
Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
[TBL] [Abstract][Full Text] [Related]
11. In whom and how to prevent glucocorticoid-induced osteoporosis.
Adachi JD; Papaioannou A
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced osteoporosis: pathogenesis and management.
Nishimura J; Ikuyama S
J Bone Miner Metab; 2000; 18(6):350-2. PubMed ID: 11052469
[TBL] [Abstract][Full Text] [Related]
13. How to prevent glucocorticoid-induced osteoporosis.
Dore RK
Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
[TBL] [Abstract][Full Text] [Related]
14. Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.
Laurent MR; Goemaere S; Verroken C; Bergmann P; Body JJ; Bruyère O; Cavalier E; Rozenberg S; Lapauw B; Gielen E
Front Endocrinol (Lausanne); 2022; 13():908727. PubMed ID: 35757436
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
Bultink IE; Baden M; Lems WF
Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of glucocorticoid induced osteoporosis].
Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M
G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
Lems WF; Saag K
Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
[TBL] [Abstract][Full Text] [Related]
19. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
Soen S
Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
[TBL] [Abstract][Full Text] [Related]
20. Management of postmenopausal osteoporosis and the prevention of fractures.
Gambacciani M; Levancini M
Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
